{"id": "1336568267419365376", "creation": 1607497681.0, "user_id": "2149170848", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 2, "quote_count": 0}}, "text": "Safety and efficacy of the ChAdOx1 nCoV-19 #vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials #coronavirus #vaccine  #covid19 #clinicaltrial #safety #efficacy https://t.co/ecZQH7tv4y @AstraZeneca https://t.co/cf3hiTpuVH", "first_save": 1634559108.199414, "hashtags": ["#VACCINE", "#CORONAVIRUS", "#VACCINE", "#COVID19", "#CLINICALTRIAL", "#SAFETY", "#EFFICACY"]}